We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+0.64%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.26B
AUM Growth
-$618M
(-11%)
Cap. Flow
-$615M
Cap. Flow
% of AUM
-11.69%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
928
New
151
Increased
197
Reduced
368
Closed
132
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$43.8M |
| 2 |
UnitedHealth
UNH
|
+$42.1M |
| 3 |
Verizon
VZ
|
+$32.3M |
| 4 |
Comcast
CMCSA
|
+$29.1M |
| 5 |
Citigroup
C
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$70.8M |
| 2 |
Apple
AAPL
|
+$38.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$36.3M |
| 4 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$31.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.72% |
| 2 | Healthcare | 17.4% |
| 3 | Technology | 16.88% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Antero Resources
AR
$10.9B
| $6.07M | 0.12% |
176,710
+153,220
| +652% | +$6.08M |
|
|
HOLX
202
DELISTED
Hologic
HOLX
| $6.03M | 0.11% |
158,470
-15,600
| -9% | -$546K |
|
203
WisdomTree
WT
$2.97B
| $6.02M | 0.11% |
274,230
+75,500
| +38% | +$1.59M |
|
|
BHI
204
DELISTED
Baker Hughes
BHI
| $5.94M | 0.11% |
96,320
-115,940
| -55% | -$7.58M |
|
205
PBF Energy
PBF
$7.29B
| $5.9M | 0.11% |
207,600
-221,099
| -52% | -$6.22M |
|
206
Progress Software
PRGS
$1.55B
| $5.83M | 0.11% |
212,138
| – | – |
|
207
F5
FFIV
$22.1B
| $5.77M | 0.11% |
+47,963
| New | +$5.9M |
|
|
EXPR
208
DELISTED
Express, Inc.
EXPR
| $5.72M | 0.11% |
15,795
+13,375
| +553% | +$4.67M |
|
|
NUAN
209
DELISTED
Nuance Communications, Inc.
NUAN
| $5.65M | 0.11% |
372,405
+29,452
| +9% | +$415K |
|
|
AZPN
210
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $5.61M | 0.11% |
123,244
-357,772
| -74% | -$16.3M |
|
211
Humana
HUM
$46.7B
| $5.6M | 0.11% |
29,291
-56,428
| -66% | -$10.5M |
|
212
Stryker
SYK
$127B
| $5.51M | 0.1% |
+57,710
| New | +$5.47M |
|
213
Qualcomm
QCOM
$176B
| $5.51M | 0.1% |
87,910
-131,820
| -60% | -$8.99M |
|
214
Norfolk Southern
NSC
$78.8B
| $5.29M | 0.1% |
60,556
-86,603
| -59% | -$8.44M |
|
|
SYNT
215
DELISTED
Syntel Inc
SYNT
| $5.25M | 0.1% |
110,561
-8,144
| -7% | -$389K |
|
216
PTC
PTC
$13.7B
| $5.23M | 0.1% |
127,472
-94,924
| -43% | -$3.75M |
|
217
Steel Dynamics
STLD
$35.6B
| $5.22M | 0.1% |
251,970
-16,600
| -6% | -$357K |
|
218
US Bancorp
USB
$99.6B
| $5.18M | 0.1% |
119,430
+65,480
| +121% | +$2.86M |
|
219
Sherwin-Williams
SHW
$78.3B
| $5.18M | 0.1% |
56,493
-21,906
| -28% | -$2.08M |
|
220
East-West Bancorp
EWBC
$17.9B
| $5.17M | 0.1% |
115,252
+1,230
| +1% | +$52.7K |
|
221
AXIS Capital
AXS
$8.59B
| $5.16M | 0.1% |
96,707
-65,342
| -40% | -$3.52M |
|
|
XL
222
DELISTED
XL Group Ltd.
XL
| $5.14M | 0.1% |
138,072
-6,100
| -4% | -$229K |
|
223
Strategy Inc
MSTR
$33.5B
| $5.08M | 0.1% |
298,540
+72,900
| +32% | +$1.28M |
|
224
Green Dot
GDOT
$753M
| $5.05M | 0.1% |
264,269
+27,900
| +12% | +$453K |
|
225
Dolby
DLB
$4.72B
| $5M | 0.1% |
126,010
-9,260
| -7% | -$367K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2015 Portfolio in Review
As of Q2 2015, Jacobs Levy Equity Management held 928 positions worth $5.26B, down 11% from $5.88B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jacobs Levy Equity Management withdrew a net $615M in Q2 2015, closing 132 positions and reducing 368 holdings. Its most notable exit was BROADCOM CORP CL-A, an estimated $31.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jacobs Levy Equity Management opened a new position in UnitedHealth worth $43.4M.
- Jacobs Levy Equity Management's largest Q2 2015 buy was UnitedHealth: 355,991 shares worth $43.4M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q2 2015, an estimated $43.8M increase.
- Jacobs Levy Equity Management's biggest Q2 2015 reduction was Microsoft, cutting an estimated $70.8M.
- Jacobs Levy Equity Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $31.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 14% of its $5.26B portfolio in Q2 2015.
- Jacobs Levy Equity Management opened 151 new positions and closed 132 in Q2 2015.
- Jacobs Levy Equity Management's portfolio value fell 11% quarter-over-quarter to $5.26B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2015, filed 14 Aug 2015.